Literature DB >> 8641170

Glucocorticoids inhibit keratinocyte growth factor production in primary dermal fibroblasts.

M Chedid1, J R Hoyle, K G Csaky, J S Rubin.   

Abstract

The participation of growth factors in wound healing and tissue repair has been well established. Previous studies demonstrated that the expression of keratinocyte growth factor (KGF) was greatly elevated shortly after injury and that topical application of KGF accelerated healing. Steroidal antiinflammatory agents, specifically glucocorticoids, markedly impair wound healing. The participation of KGF in wound healing led us to examine the effect of glucocorticoids on KGF production. The addition of dexamethasone significantly reduced the level of constitutively produced KGF messenger RNA, protein, and bioactivity in conditioned medium from dermal fibroblasts. This inhibitory effect was observed with a variety of glucocorticoids, whereas nonsteroidal antiinflammatory compounds had little effect on KGF synthesis. The mechanisms by which dexamethasone decreased KGF production include a combination of a diminished transcriptional rate and destabilization of the KGF messenger RNA. Cytokines such as interleukin-1 alpha, platelet-derived growth factor-BB, and transforming growth factor-alpha, typically up-regulated during wound healing, augment KGF expression by dermal fibroblasts. We determined that dexamethasone also blocked this inductive effect. These results suggest that glucocorticoids could inhibit KGF production in the setting of wound repair, which may contribute to the impairment of healing associated with glucocorticoid use.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641170     DOI: 10.1210/endo.137.6.8641170

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Analysis of the cellular basis of keratinocyte growth factor overexpression in inflammatory bowel disease.

Authors:  P W Finch; A L Cheng
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

2.  Keratinocyte growth factor in inflammatory bowel disease. Increased mRNA transcripts in ulcerative colitis compared with Crohn's disease in biopsies and isolated mucosal myofibroblasts.

Authors:  M Bajaj-Elliott; E Breese; R Poulsom; P D Fairclough; T T MacDonald
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

3.  Cushing disease in a patient with nonbullous congenital ichthyosiform erythroderma: lessons in avoiding glucocorticoids in ichthyosis.

Authors:  Iris R Hartley; Julia Costa Beber Nunes; Maya Lodish; Constantine A Stratakis
Journal:  J Pediatr Endocrinol Metab       Date:  2019-08-27       Impact factor: 1.634

Review 4.  Skin manifestations of Cushing's syndrome.

Authors:  Constantine A Stratakis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

5.  Prevention and treatment of mice paw edema by near-infrared low-level laser therapy on lymph nodes.

Authors:  Daiane Thais Meneguzzo; Luciana Almeida Lopes; Rodney Pallota; Leila Soares-Ferreira; Rodrigo Álvaro Brandão Lopes-Martins; Martha Simões Ribeiro
Journal:  Lasers Med Sci       Date:  2012-08-23       Impact factor: 3.161

6.  Differences in skin lesions of endogenous and exogenous Cushing's patients.

Authors:  Fatma Erden; Murat Borlu; Yasin Simsek; Hasan Fahrettin Kelestemur
Journal:  Postepy Dermatol Alergol       Date:  2018-03-21       Impact factor: 1.837

7.  Combined Lacrimal Passage Probing and Tobramycin/Dexamethasone Ophthalmic Ointment Infiltration: A Minimally Invasive Surgical Procedure for Incomplete Nasolacrimal Duct Obstruction.

Authors:  Jianjiang Xu; Jiaxu Hong; Xinghuai Sun; Zuguo Liu; Alireza Mashaghi; Takenori Inomata; Yi Lu; Yimin Li; Dan Wu; Yujing Yang; Anji Wei; Yujin Zhao; Chun Lu
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.